Follow
Xiaoming Xu
Xiaoming Xu
Office of Pharmaceutical Quality Research, US FDA
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment
X Xu, MA Khan, DJ Burgess
International Journal of Pharmaceutics 419 (1-2), 52-59, 2011
1742011
Freeze-Anneal-Thaw Cycling of Unilamellar Liposomes: Effect on Encapsulation Efficiency
AP Costa, X Xu, DJ Burgess
Pharmaceutical Research, 2013
1482013
Predicting hydrophilic drug encapsulation inside unilamellar liposomes
X Xu, MA Khan, DJ Burgess
International Journal of Pharmaceutics 423 (2), 410-418, 2012
1412012
A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale
X Xu, MA Khan, DJ Burgess
International Journal of Pharmaceutics 423 (2), 543-553, 2012
1382012
Protein encapsulation in unilamellar liposomes: High encapsulation efficiency and a novel technique to assess lipid-protein interaction
X Xu, A Costa, DJ Burgess
Pharmaceutical Research 29, 1919-1931, 2012
1242012
A two-stage reverse dialysis in vitro dissolution testing method for targeted liposomes
X Xu, MA Khan, DJ Burgess
International Journal of Pharmaceutics 426 (1-2), 211-218, 2012
1122012
Development of performance matrix for generic product equivalence of acyclovir topical creams
YSR Krishnaiah, X Xu, Z Rahman, Y Yang, U Katragadda, R Lionberger, ...
International journal of pharmaceutics 475 (1-2), 110-122, 2014
832014
Application of quality by design to formulation and processing of protein liposomes
X Xu, AP Costa, MA Khan, DJ Burgess
International Journal of Pharmaceutics 434 (1-2), 349-359, 2012
742012
Formulation and Process Factors Influencing Product Quality and In Vitro Performance of Ophthalmic Ointments
X Xu, M Al-Ghabeish, Z Rahman, YSR Krishnaiah, F Yerlikaya, Y Yang, ...
International Journal of Pharmaceutics, 2015
712015
Probing the mechanism of bupivacaine drug release from multivesicular liposomes
S Manna, Y Wu, Y Wang, B Koo, L Chen, P Petrochenko, Y Dong, S Choi, ...
Journal of Controlled Release 294, 279-287, 2019
662019
Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach
S Kumar, X Xu, R Gokhale, DJ Burgess
International Journal of Pharmaceutics 464 (1-2), 34-45, 2014
642014
Quality by Design approach for studying the impact of formulation and process variables on product quality of oral disintegrating films
S Mazumder, N Pavurala, P Manda, X Xu, C Cruz, YSR Krishnaiah
International Journal of Pharmaceutics 527 (1-2), 151-160, 2017
512017
Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion
Z Rahman, X Xu, U Katragadda, YSR Krishnaiah, L Yu, MA Khan
Molecular pharmaceutics 11 (3), 787-799, 2014
482014
Assessing impact of formulation and process variables on in-vitro performance of directly compressed abuse deterrent formulations
Z Rahman, Y Yang, M Korang-Yeboah, A Siddiqui, X Xu, M Ashraf, ...
International journal of pharmaceutics 502 (1-2), 138-150, 2016
472016
Formulation and characterization of curcumin loaded polymeric micelles produced via continuous processing
A Gupta, AP Costa, X Xu, SL Lee, CN Cruz, Q Bao, DJ Burgess
International journal of pharmaceutics 583, 119340, 2020
432020
Kinetics of Drug Release from Ointments: Role of Transient-Boundary Layer
X Xu, M Al-Ghabeish, YSR Krishnaiah, Z Rahman, MA Khan
International Journal of Pharmaceutics, 2015
412015
Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment
M Al-Ghabeish, X Xu, YSR Krishnaiah, Z Rahman, Y Yang, MA Khan.
International Journal of Pharmaceutics, 2015
362015
Effect of ionic strength on the temperature‐dependent behavior of hydroxypropyl methylcellulose solution and matrix tablet
X Xu, Y Song, Y Wang, X Liu, Q Ping
Journal of Applied Polymer Science 102 (4), 4066-4074, 2006
332006
Analytical considerations for measuring the globule size distribution of cyclosporine ophthalmic emulsions
PE Petrochenko, N Pavurala, Y Wu, SY Wong, H Parhiz, K Chen, SM Patil, ...
International journal of pharmaceutics 550 (1-2), 229-239, 2018
312018
Risk based in vitro performance assessment of extended release abuse deterrent formulations
X Xu, A Gupta, M Al-Ghabeish, SN Calderon, MA Khan
International Journal of Pharmaceutics 500 (1-2), 255-267, 2016
302016
The system can't perform the operation now. Try again later.
Articles 1–20